Metraipolis › archive › dc_8eb02fcaa35c

Survival Impact of Bevacizumab According to Chemotherapy Response Score in Advanced High-Grade Serous Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy — Europe PMC PMID:42795011

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42795011
DOI: 10.3390/cancers18183045
License (as archived): solo-consultazione
Archived: 2026-10-08T03:15:56.585Z
SHA-256 of the archived text: 148e5a7050d30667bbfa98963cdd225e8a215e302f7ab12f1f18c1b52ca4293d
Stable URL of this page: https://metraipolis.com/documento/dc_8eb02fcaa35c

How to cite

Survival Impact of Bevacizumab According to Chemotherapy Response Score in Advanced High-Grade Serous Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy — Europe PMC PMID:42795011 — Europe PMC (en), https://europepmc.org/article/MED/42795011 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8eb02fcaa35c (Metraipolis archive dc_8eb02fcaa35c, sha256 148e5a7050d30667bbfa98963cdd225e8a215e302f7ab12f1f18c1b52ca4293d)

BibTeX

@misc{dc8eb02fcaa35c,
  title = {Survival Impact of Bevacizumab According to Chemotherapy Response Score in Advanced High-Grade Serous Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy — Europe PMC PMID:42795011},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795011},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8eb02fcaa35c; sha256 148e5a7050d30667bbfa98963cdd225e8a215e302f7ab12f1f18c1b52ca4293d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795011. Agents can read the archived copy with the MCP tool read_document.